All Stories

  1. Does Serum Creatinine Reflect Muscle Mass in Patients with Kidney Failure?

    Article • Journal of the American Society of Nephrology, November 2023, Wolters Kluwer Health

    Sankar Navaneethan

  2. Effects of the 2021 CKD-EPI Creatinine eGFR Equation among a National US Veteran Cohort

    Article • Clinical Journal of the American Society of Nephrology, November 2021, American Society of Nephrology

    Sankar Navaneethan

  3. Considerations in the Study of Body Mass Index Variability

    Article • Journal of the American Society of Nephrology, October 2021, American Society of Nephrology

    Sankar Navaneethan

  4. Are All SGLT2 Inhibitors Created Equal?

    Article • Clinical Journal of the American Society of Nephrology, September 2021, American Society of Nephrology

    Sankar Navaneethan

  5. Effects of Treatment of Metabolic Acidosis in CKD

    Article • Clinical Journal of the American Society of Nephrology, June 2019, American Society of Nephrology

    Sankar Navaneethan

  6. Facility-Level Variations in Kidney Disease Care among Veterans with Diabetes and CKD

    Article • Clinical Journal of the American Society of Nephrology, November 2018, American Society of Nephrology

    Sankar Navaneethan

  7. Facility-level variation in diabetes and blood pressure control in patients with diabetes: Findings from the Veterans Affairs national database

    Article • Clinical Cardiology, August 2017, Wiley

    Sankar Navaneethan

  8. Pragmatic Randomized, Controlled Trial of Patient Navigators and Enhanced Personal Health Records in CKD

    Article • Clinical Journal of the American Society of Nephrology, August 2017, American Society of Nephrology

    Sankar Navaneethan

  9. Omega‐3 Fatty Acids (Fish Oil) Supplementation and Albuminuria: Not a Slam Dunk

    Article • Journal of the American Heart Association, July 2017, Wolters Kluwer Health

    Sankar Navaneethan

  10. BP Targets in Older Adults with CKD: Additional Evidence, but Uncertainty Continues

    Article • Clinical Journal of the American Society of Nephrology, August 2015, American Society of Nephrology

    Sankar Navaneethan

  11. Chronic Renal Insufficiency Cohort Study (CRIC): Overview and Summary of Selected Findings

    Article • Clinical Journal of the American Society of Nephrology, August 2015, American Society of Nephrology

    Sankar Navaneethan, Chi-yuan Hsu

  12. Implantable Cardioverter-Defibrillators in Patients with CKD: A Propensity-Matched Mortality Analysis

    Article • Clinical Journal of the American Society of Nephrology, June 2015, American Society of Nephrology

    Dr Jesse Schold, Sankar Navaneethan, Serge Harb

  13. Urinary Creatinine Excretion, Bioelectrical Impedance Analysis, and Clinical Outcomes in Patients with CKD: The CRIC Study

    Article • Clinical Journal of the American Society of Nephrology, November 2014, American Society of Nephrology

    Sankar Navaneethan, Dr. Francis P Wilson, Peter Reese

  14. Presence and Outcomes of Kidney Disease in Patients with Pulmonary Hypertension

    Article • Clinical Journal of the American Society of Nephrology, February 2014, American Society of Nephrology

    Dr Jesse Schold, Sankar Navaneethan, Gustavo Heresi

  15. Aldosterone Breakthrough during Angiotensin Receptor Blocker Use: More Questions than Answers?

    Article • Clinical Journal of the American Society of Nephrology, August 2013, American Society of Nephrology

    Sankar Navaneethan

  16. Cardiac Resynchronization Therapy in CKD: A Systematic Review

    Article • Clinical Journal of the American Society of Nephrology, May 2013, American Society of Nephrology

    Sankar Navaneethan

  17. Metabolic Syndrome, ESRD, and Death in CKD

    Article • Clinical Journal of the American Society of Nephrology, February 2013, American Society of Nephrology

    Dr Jesse Schold, srinivasan Beddhu, Sankar Navaneethan

  18. Impact of Navigators on Completion of Steps in the Kidney Transplant Process: A Randomized, Controlled Trial

    Article • Clinical Journal of the American Society of Nephrology, July 2012, American Society of Nephrology

    Sankar Navaneethan

  19. Fibroblast Growth Factor 23 and Inflammation in CKD

    Article • Clinical Journal of the American Society of Nephrology, May 2012, American Society of Nephrology

    Sankar Navaneethan, Tamara Isakova, Dr. Lavinia A Negrea

  20. Aldosterone antagonists for preventing the progression of chronic kidney disease

    Article • January 2008, Wiley

    Sagar U Nigwekar, Sankar Navaneethan